Role of miRNA-21 in the diagnosis and prediction of treatment efficacy of primary central nervous system lymphoma.

Yang, Kunpeng; Wang, Shuye; Cheng, Yafeng; Tian, Yaoyao; Hou, Jinxiao

Yang, Kunpeng; Wang, Shuye; Cheng, Yafeng; Tian, Yaoyao; Hou, Jinxiao.

Afiliação

Yang K; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Wang S; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Cheng Y; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Tian Y; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.
Hou J; Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

Oncol Lett ; 17(3): 3475-3481, 2019 Mar.

Article em En | MEDLINE | ID: mdl-30867786

Palavras-chave

diagnostic marker; efficacy evaluation marker; glioblastoma; microRNA-21; primary central nervous system lymphoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google